Why do AQP4-seronegative NMOSD cases show distinct clinical features like bilateral ON and monophasic course?

OPEN

The abstract notes that AQP4-seronegative NMOSD cases differ systematically from seropositive cases in presentation and disease course, but provides no mechanistic explanation. Understanding this could reveal distinct pathophysiological pathways within NMOSD. Gap type: unexplained_observation Source paper: Uncommon Non-MS Demyelinating Disorders of the Central Nervous System. (2025, Current neurology and neuroscience reports, PMID:40591029)

Priority: 0.79 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why do AQP4-seronegative NMOSD cases show distinct clinical features like bilateral ON and monophasic course? is a 0.79 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why do AQP4-seronegative NMOSD cases show distinct clinical features like bilateral ON and monophasic course? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (2)

AQP4NMOSDMOGADNMOSD

biomarker for (9)

AQP4-AntibodyNMOSDAQP4NMOSDNMOSDOptic Chiasm T2 LesionNMOSDLETMNMOSDArea Postrema T2 Lesion
▸ Show 4 more

correlates with (1)

NMOSDMultiple Sclerosis

involved in (1)

NMOSDDemyelinating Disease

mediates (1)

NEUROINFLAMMATIONNMOSD

regulates (3)

MOGADNMOSDAQP4NMOSDAQUAPORIN-4NMOSD

treats (3)

AQUAPORIN-4NMOSDMOGADNMOSDAQP4NMOSD

upregulates (1)

AQP4NMOSD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps